171 related articles for article (PubMed ID: 36860098)
1. Placenta-mediated pregnancy complications in women with a history of late fetal loss and placental infarction without thrombophilia: risk of recurrence and efficacy of pharmacological prophylactic interventions. A 10-year retrospective study.
Borella F; Marozio L; Bertschy G; Botta G; Bertero L; Cassoni P; Maina A; Cosma S; Benedetto C
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2183748. PubMed ID: 36860098
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD;
Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497
[TBL] [Abstract][Full Text] [Related]
3. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
Kupferminc MJ; Kliger C; Rimon E; Asher-Landsberg J; Skornick-Rapaport A; Gamzu R; Yogev Y
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8055-8061. PubMed ID: 34154497
[TBL] [Abstract][Full Text] [Related]
4. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia.
Kupferminc M; Rimon E; Many A; Maslovitz S; Lessing JB; Gamzu R
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):123-6. PubMed ID: 21192252
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis.
Chen J; Huai J; Yang H
BMC Pregnancy Childbirth; 2024 Jan; 24(1):68. PubMed ID: 38233773
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis.
Cruz-Lemini M; Vázquez JC; Ullmo J; Llurba E
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1126-S1144.e17. PubMed ID: 34301348
[TBL] [Abstract][Full Text] [Related]
7. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
Areia AL; Fonseca E; Areia M; Moura P
Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
[TBL] [Abstract][Full Text] [Related]
9. Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?
Kalk JJ; Huisjes AJ; de Groot CJ; van Beek E; van Pampus MG; Spaanderman ME; van Eyck J; Oei SG; Bezemer PD; de Vries JI
Neth J Med; 2004 Mar; 62(3):83-7. PubMed ID: 15209472
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulants to prevent recurrent placenta-mediated pregnancy complications: Is it time to put the needles away?
Skeith L; Rodger M
Thromb Res; 2017 Mar; 151 Suppl 1():S38-S42. PubMed ID: 28262232
[TBL] [Abstract][Full Text] [Related]
11. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
[TBL] [Abstract][Full Text] [Related]
12. [Thrombophilia, preeclampsia and other pregnancy complications].
Vucić N; Frleta M; Petrović D; Ostojić V
Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
[TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.
de Vries JI; van Pampus MG; Hague WM; Bezemer PD; Joosten JH;
J Thromb Haemost; 2012 Jan; 10(1):64-72. PubMed ID: 22118560
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of thrombophilia, anticoagulant treatment, and maternal variables as predictors of placenta-mediated pregnancy complications: an extensive analysis.
Lafalla O; Esteban LM; Lou AC; Cornudella R; Domínguez M; Sanz G; Borque-Fernando Á
J Matern Fetal Neonatal Med; 2021 Feb; 34(4):588-598. PubMed ID: 31018724
[No Abstract] [Full Text] [Related]
15. Is thrombophilia a risk factor for placenta-mediated pregnancy complications?
Hoffmann E; Hedlund E; Perin T; Lyndrup J
Arch Gynecol Obstet; 2012 Sep; 286(3):585-9. PubMed ID: 22543699
[TBL] [Abstract][Full Text] [Related]
16. Pre-pregnant prediction of recurrent preeclampsia in normotensive thrombophilic formerly preeclamptic women receiving prophylactic antithrombotic medication.
Spaanderman ME; Aardenburg R; Ekhart TH; van Eyndhoven HW; de Leeuw PW; Peeters LL
J Soc Gynecol Investig; 2005 Feb; 12(2):112-7. PubMed ID: 15695106
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications.
Rodger MA; Carrier M; Le Gal G; Martinelli I; Perna A; Rey E; de Vries JI; Gris JC;
Blood; 2014 Feb; 123(6):822-8. PubMed ID: 24357725
[TBL] [Abstract][Full Text] [Related]
18. Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction.
McLaughlin K; Hobson SR; Chandran AR; Agrawal S; Windrim RC; Parks WT; Bowman AW; Sovio U; Smith GC; Kingdom JC
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1145-S1156.e1. PubMed ID: 34461078
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
Riyazi N; Leeda M; de Vries JI; Huijgens PC; van Geijn HP; Dekker GA
Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):49-54. PubMed ID: 9758259
[TBL] [Abstract][Full Text] [Related]
20. Early Prophylactic Enoxaparin for the Prevention of Preeclampsia and Intrauterine Growth Restriction: A Randomized Trial.
Llurba E; Bella M; Burgos J; Mazarico E; Gómez-Roig MD; De Diego R; Martínez-Astorquiza T; Alijotas-Reig J; Sánchez-Durán MÁ; Sánchez O; Carreras E; Cabero L
Fetal Diagn Ther; 2020; 47(11):824-833. PubMed ID: 33472201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
